{"id":"https://openalex.org/W2005165955","doi":"https://doi.org/10.1016/j.bmc.2008.05.022","title":"In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives","display_name":"In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives","alternate_titles":[],"publication_year":2008,"publication_date":"2008-05-11","ids":{"openalex":"https://openalex.org/W2005165955","doi":"https://doi.org/10.1016/j.bmc.2008.05.022","mag":"2005165955","pmid":"https://pubmed.ncbi.nlm.nih.gov/18513976"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmc.2008.05.022","doi":"https://doi.org/10.1016/j.bmc.2008.05.022","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmc.2008.05.022","pdf_url":null,"source":{"id":"https://openalex.org/S10422866","display_name":"Bioorganic & Medicinal Chemistry","issn_l":"0968-0896","issn":["0968-0896","1464-3391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005165955"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045885914","display_name":"Georges Moarbess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Georges Moarbess","raw_affiliation_strings":["Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055342883","display_name":"Carine Deleuze\u2010Masqu\u00e9fa","orcid":"https://orcid.org/0000-0002-4086-5178","observed_orcids":["https://orcid.org/0000-0002-4086-5178"]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Carine Deleuze-Masquefa","raw_affiliation_strings":["Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040976146","display_name":"Vanessa Bonnard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Vanessa Bonnard","raw_affiliation_strings":["Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062265274","display_name":"St\u00e9phanie Paniagua-Gayraud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phanie Gayraud-Paniagua","raw_affiliation_strings":["Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030683078","display_name":"Jean-R\u00e9mi Vidal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-R\u00e9mi Vidal","raw_affiliation_strings":["Centre R\u00e9gional de Lutte contre le Cancer, Val d\u2019Aurelle, Rue de la Croix Verte, 34000 Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre R\u00e9gional de Lutte contre le Cancer, Val d\u2019Aurelle, Rue de la Croix Verte, 34000 Montpellier, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111684769","display_name":"Fran\u00e7oise Bressolle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7oise Bressolle","raw_affiliation_strings":["Centre R\u00e9gional de Lutte contre le Cancer, Val d\u2019Aurelle, Rue de la Croix Verte, 34000 Montpellier, France","Laboratoire de Pharmacocin\u00e9tique Clinique, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre R\u00e9gional de Lutte contre le Cancer, Val d\u2019Aurelle, Rue de la Croix Verte, 34000 Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"Laboratoire de Pharmacocin\u00e9tique Clinique, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110411354","display_name":"Fr\u00e9d\u00e9ric Pinguet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fr\u00e9d\u00e9ric Pinguet","raw_affiliation_strings":["Centre R\u00e9gional de Lutte contre le Cancer, Val d\u2019Aurelle, Rue de la Croix Verte, 34000 Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre R\u00e9gional de Lutte contre le Cancer, Val d\u2019Aurelle, Rue de la Croix Verte, 34000 Montpellier, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066990257","display_name":"Pierre\u2010Antoine Bonnet","orcid":"https://orcid.org/0000-0001-8579-4150","observed_orcids":["https://orcid.org/0000-0001-8579-4150"]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre-Antoine Bonnet","raw_affiliation_strings":["Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacochimie et Biomol\u00e9cules, EA 4215, Facult\u00e9 de Pharmacie, Universit\u00e9 Montpellier I, 15 av. Charles Flahault, BP 14491, 34 093 Montpellier Cedex 5, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5055342883"],"corresponding_institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4387153574"],"apc_list":{"value":3960,"currency":"USD","value_usd":3960},"apc_paid":null,"fwci":2.1959,"has_fulltext":false,"cited_by_count":130,"citation_normalized_percentile":{"value":0.86106689,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"16","issue":"13","first_page":"6601","last_page":"6610"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7390000224113464},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.9430000185966492},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7509999871253967},{"id":"https://openalex.org/keywords/a375-cells","display_name":"A375 cells","score":0.7099999785423279},{"id":"https://openalex.org/keywords/xenograft-tumor-model","display_name":"xenograft tumor model","score":0.597000002861023},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7730000019073486},{"id":"https://openalex.org/keywords/imiquimod","display_name":"imiquimod","score":0.6579999923706055},{"id":"https://openalex.org/keywords/fotemustine","display_name":"fotemustine","score":0.9639999866485596}],"concepts":[{"id":"https://openalex.org/C2780362310","wikidata":"https://www.wikidata.org/wiki/Q419930","display_name":"Quinoxaline","level":2,"score":0.8269340991973877},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8062543272972107},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7729272842407227},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.688599705696106},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6526938080787659},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.560681164264679},{"id":"https://openalex.org/C2779112978","wikidata":"https://www.wikidata.org/wiki/Q423417","display_name":"Imiquimod","level":2,"score":0.4911644160747528},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4817224144935608},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25905314087867737},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14707908034324646},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08345362544059753},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.bmc.2008.05.022","doi":"https://doi.org/10.1016/j.bmc.2008.05.022","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmc.2008.05.022","pdf_url":null,"source":{"id":"https://openalex.org/S10422866","display_name":"Bioorganic & Medicinal Chemistry","issn_l":"0968-0896","issn":["0968-0896","1464-3391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:18513976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18513976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04828480v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-04828480","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Bioorganic and Medicinal Chemistry, 2008, 16 (13), pp.6601-6610. &#x27E8;10.1016/j.bmc.2008.05.022&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322363","display_name":"Ligue Contre le Cancer","ror":"https://ror.org/00rkrv905"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1883933571","https://openalex.org/W1972776583","https://openalex.org/W1974912240","https://openalex.org/W1980313944","https://openalex.org/W1982530463","https://openalex.org/W2003694618","https://openalex.org/W2018665096","https://openalex.org/W2027357563","https://openalex.org/W2055157433","https://openalex.org/W2058188768","https://openalex.org/W2060272530","https://openalex.org/W2079489649","https://openalex.org/W2085122016","https://openalex.org/W2114847324","https://openalex.org/W2118315567","https://openalex.org/W2127777737","https://openalex.org/W2170459272","https://openalex.org/W2171460417","https://openalex.org/W2406781276","https://openalex.org/W2439993272"],"related_works":["https://openalex.org/W2106428807","https://openalex.org/W3087347754","https://openalex.org/W2049964386","https://openalex.org/W120051239","https://openalex.org/W4301398919","https://openalex.org/W2054851509","https://openalex.org/W2901807117","https://openalex.org/W2950175790","https://openalex.org/W2743654770","https://openalex.org/W2951637080"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005165955","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
